ProfileGDS4718 / 210448_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 80% 64% 59% 66% 63% 81% 69% 72% 68% 61% 95% 65% 79% 76% 78% 66% 56% 58% 52% 60% 65% 60% 66% 75% 68% 54% 62% 62% 72% 69% 57% 76% 65% 55% 85% 83% 85% 89% 54% 75% 68% 62% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5752466
GSM549102patient 115, normal, homogenized [OPG study]7.7606680
GSM549104patient 119, normal, homogenized [OPG study]6.4609764
GSM549108patient 138, normal, homogenized [OPG study]6.1130659
GSM549119patient 077, normal, homogenized [OPG study]6.5477866
GSM549133patient 032, cancer, homogenized [OPG study]6.3590563
GSM549139patient 042, cancer, homogenized [OPG study]7.9546681
GSM549099patient 107, normal, homogenized [OPG study]6.7814669
GSM549109patient 139, normal, homogenized [OPG study]7.0419172
GSM549110patient 046, normal, homogenized [OPG study]6.6526268
GSM549114patient 063, normal, homogenized [OPG study]6.1830561
GSM549122patient 082, normal, homogenized [OPG study]10.247695
GSM549134patient 033, cancer, homogenized [OPG study]6.4270965
GSM549136patient 036, cancer, homogenized [OPG study]7.820179
GSM549140patient 044, cancer, homogenized [OPG study]7.4837676
GSM549111patient 047, normal, homogenized [OPG study]7.640878
GSM549113patient 057, normal, homogenized [OPG study]6.5175666
GSM549132patient 031, cancer, homogenized [OPG study]5.8498656
GSM549137patient 038, cancer, homogenized [OPG study]5.9951558
GSM549142patient 047, cancer, homogenized [OPG study]5.7344952
GSM549100patient 110, normal, homogenized [OPG study]6.1135160
GSM549107patient 135, normal, homogenized [OPG study]6.4735865
GSM549115patient 068, normal, homogenized [OPG study]6.1101160
GSM549116patient 072, normal, homogenized [OPG study]6.5860266
GSM549120patient 078, normal, homogenized [OPG study]7.3344375
GSM549131patient 030, cancer, homogenized [OPG study]6.7393968
GSM549118patient 074, normal, homogenized [OPG study]5.7493454
GSM549129patient 027, cancer, homogenized [OPG study]6.3350962
GSM549123patient 088, normal, homogenized [OPG study]6.2358962
GSM549124patient 006, cancer, homogenized [OPG study]6.9746172
GSM549126patient 015, cancer, homogenized [OPG study]6.7914569
GSM549128patient 025, cancer, homogenized [OPG study]5.9614357
GSM549103patient 117, normal, homogenized [OPG study]7.3374876
GSM549117patient 073, normal, homogenized [OPG study]6.4092365
GSM549138patient 041, cancer, homogenized [OPG study]5.80355
GSM549141patient 045, cancer, homogenized [OPG study]8.5735985
GSM549130patient 028, cancer, homogenized [OPG study]8.1771883
GSM549101patient 111, normal, homogenized [OPG study]8.4416285
GSM549105patient 128, normal, homogenized [OPG study]9.0000689
GSM549106patient 134, normal, homogenized [OPG study]5.6914754
GSM549112patient 048, normal, homogenized [OPG study]7.3714275
GSM549125patient 011, cancer, homogenized [OPG study]6.7261168
GSM549127patient 024, cancer, homogenized [OPG study]6.3083362
GSM549135patient 035, cancer, homogenized [OPG study]9.599192